[1] 吴双胜, 潘阳, 段玮, 等. 北京市一起境外输入无症状感染者相关新冠肺炎聚集性疫情的溯源调查[J]. 国际病毒学杂志, 2021, 28(3): 187-191. [2] 王达, 董梁, 卿松, 等. 新型冠状病毒核酸检测中的思维误区[J]. 中华医院感染学杂志, 2020, 30(8): 1167-1170. [3] Martel F, Gründemann D, Schömig E. A simple method for elimination of false positive results in RT-PCR[J]. J Biochem Mol Biol, 2002, 35(2): 248-250. [4] 鲍春梅, 李波, 王欢, 等. 新型冠状病毒的实验室生物风险评估与风险控制[J]. 传染病信息, 2020, 33(1): 90-95. [5] Salido R A, Cantú V J, Clark A E, et al. Analysis of SARS-CoV-2 RNA persistence across indoor surface materials reveals best practices for environmental monitoring programs[J]. mSystems, 2021, 6(6): e0113621. [6] Gehrke S G, Förderer C, Weiskirchen R, et al. Cold traps as reliable devices for quantitative determination of SARS-CoV-2 load in aerosols[J]. Environ Monit Assess, 2021, 193(12): 778. [7] 中华医学会检验医学分会. 2019新型冠状病毒肺炎临床实验室生物安全防护专家共识[J]. 中华检验医学杂志, 2020, 43(3): 203-208. [8] 童永清, 汪明, 徐万洲, 等. 新型冠状病毒核酸检测临床实验室操作规范的建议[J]. 中华检验医学杂志, 2020, 43(3): 209-212. [9] 李夫,张代涛, 贾蕾, 等. 环境样本新型冠状病毒核酸检测阳性结果评估及处置建议[J]. 国际病毒学杂志, 2021, 28(3): 177-181. [10] Lippi G, Simundic A M, Plebani M. Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19)[J]. Clin Chem Lab Med, 2020, 58(7): 1070-1076. [11] 华文浩, 盛琳君, 宋丽红, 等. 生物安全Ⅱ级实验室开展新型冠状病毒检测的风险评估与防控[J]. 中华检验医学杂志, 2020, 43(4): 373-378. [12] 刘佳, 宋春丽, 陶庆春, 等. 实验室检测感染新型冠状病毒标本的高危因素及安全防护研究[J]. 标记免疫分析与临床, 2020, 27(5): 914-916. [13] Green M R, Sambrook J. Removing DNA contamination from RNA samples by treatment with RNase-free DNase Ⅰ[J]. Cold Spring Harb Protoc, 2019, 2019(10). [14] Paska C, Barta I, Drozdovszky O, et al. Elimination of bacterial DNA during RNA isolation from sputum: bashing bead vortexing is preferable over prolonged DNase treatment[J]. PLoS One, 2019, 14(3): e0214609. |